| Generator: | https://wordpress.org/?v=6.4.3 |
| Docs: | http://blogs.law.harvard.edu/tech/rss |
Daily News Spotlight
Johnson’s Vaccine 94% Effective against Covid: Study
A two-dose version of Johnson & Johnson’s coronavirus vaccination provides 94 percent protection against symptomatic infection, according to the company, making the Janssen vaccine comparable to Moderna’s or Pfizer’s two-dose regimen. Furthermore, adding a booster dose to a single vaccine shot increased immunity even more, according to the business, and should provide strong protection against […]
Johnson’s Vaccine 94% Effective against Covid: Study
Editorial Staff